Atomoxetine (Strattera) has recently been approved for the treatment of ADHD.It differs from traditional psychostimulant medications in what dimension(s)?
A)it is more selective in its actions, primarily selectively inhibiting norepinephrine reuptake.
B)in contrast to psychostimulants, it has no abuse liability
C)its efficacy is greater than that shown with psychostimulants
D)only a and b above

Question

Quizplus · Accepted Answer

Atomoxetine is more selective in its actions, primarily selectively inhibiting norepinephrine reuptake, which is different from traditional psychostimulant medications. Additionally, it has no abuse liability, which is another dimension that differs it from traditional psychostimulants. However, its efficacy is not greater than that shown with psychostimulants.

Atomoxetine (Strattera) Has Recently Been Approved for the Treatment of ADHD.It